Excessive Daytime Sleepiness and Sudden-Onset Sleep in Parkinson Disease
Open Access
- 23 January 2002
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 287 (4), 455-463
- https://doi.org/10.1001/jama.287.4.455
Abstract
The new non-ergot dopamine agonists ropinirole and pramipexole are effective options for treating Parkinson disease (PD).1 Recently published data2,3 supporting the potential of delaying the onset of dyskinesias have provided a strong incentive to use the medications as monotherapy early in this disease. Somnolence is a recognized adverse effect of dopamine agonists.4 The safety of driving while taking these medications has become the subject of recent debate.Keywords
This publication has 13 references indexed in Scilit:
- Non‐Ergot Dopamine Agonist‐Induced Sleep AttacksPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2000
- Sleep attacks (sleep episodes) with pergolideThe Lancet, 2000
- Fatigue in Patients with Parkinson’s DiseaseBehavioural Neurology, 2000
- Road accidents caused by drivers falling asleepAccident Analysis & Prevention, 1999
- Ropinirole and pramipexole, the new agonists.Canadian Journal of Neurological Sciences, 1999
- Falling asleep at the wheel: Motor vehicle mishaps in persons taking pramipexole and ropiniroleNeurology, 1999
- Sleepiness, Driving, and Motor Vehicle CrashesJAMA, 1998
- Falling asleep whilst driving: are drivers aware of prior sleepiness?International journal of legal medicine, 1998
- Can drivers avoid falling asleep at the wheel? Relationship between awareness of sleepiness and ability to predict sleep onset : A. Itoi, R. Cilveti, M. Voth, B. Dantz, P. Hyde, A. Gupta, W.C. Dement, AAA Foundation for Traffic Safety, February 8, 1993Journal of Safety Research, 1997
- ParkinsonismNeurology, 1967